Tumor suppression by ARF: Gatekeeper and caretaker

Cell Cycle

Volumn 9, Issue 1, 2010, Pages 86-89

  Dominguez Brauer, Carmen ^a   Brauer, Patrick M ^a   Chen, Yi Ju ^a   Pimkina, Julia ^b   Raychaudhuri, Pradip ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

ARF; DNA repair; E2F4; Tumor suppressor; XPC

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; PROTEIN P53; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F;

CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL PROLIFERATION; CHROMOSOME; GENE SILENCING; GENOMIC INSTABILITY; HUMAN; MELANOMA; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REPRESSOR GENE; REVIEW; TRANSCRIPTION INITIATION;

PYRONIA TITHONUS;

EID: 74549135887     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.1.10350     Document Type: Review

References (48)

1. Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 2005; 576:22-38.
2. INK4b genes. Oncogene 1995; 11:635-45.
3. ARF. Cell 1997; 91:649-59.
4. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-31.
5. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9.
6. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299-303.
7. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998; 92:725-34.
8. Serrano M. The INK4a/ARF locus in murine tumorigenesis. Carcinogenesis 2000; 21:865-9.
9. Carnero A, Hudson JD, Hannon GJ, Beach DH. Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model. Nucleic Acids Res 2000; 28:2234-41.
10. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, et al. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev 2000; 14:2358-65.
11. Eymin B, Karayan L, Seite P, Brambilla C, Brambilla E, Larsen CJ, et al. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 2001; 20:1033-41.
12. 2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 2003; 22:1822-35.
13. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Starck L, Guner D, et al. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Baxindependent apoptosis. Oncogene 2002; 21:3149-61.
14. ARF tumor suppressor. Biochem Biophys Res Commun 2002; 295:621-9.
15. Yarbrough WG, Bessho M, Zanation A, Bisi JE, Xiong Y. Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res 2002; 62:1171-7.
16. Sherr CJ. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6:663-73.
17. Datta A, Sen J, Hagen J, Korgaonkar CK, Caffrey M, Quelle DE, et al. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF. Mol Cell Biol 2005; 25:8024-36.
18. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, et al. E2F integrates cell cycle progression with DNA repair, replication and G(2)/M checkpoints. Genes Dev 2002; 16:245-56.
19. Takahashi Y, Rayman JB, Dynlacht BD. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 2000; 14:804-16.
20. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 2000; 20:5797-807.
21. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, et al. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 2002; 16:933-47.
22. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, et al. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 2004; 16:399-411.
23. Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D. The subcellular localization of E2F-4 is cell cycle dependent. Proc Natl Acad Sci USA 1997; 94:5095-100.
24. Bindra RS, Glazer PM. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene 2007; 26:2048-57.
25. Bindra RS, Gibson SL, Meng A, Westermark U, Jasin M, Pierce AJ, et al. Hypoxia-induced downregulation of BRCA1 expression by E2Fs. Cancer Res 2005; 65:11597-604.
26. Bindra RS, Glazer PM. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res 2005; 569:75-85.
27. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996; 56:5754-7.
28. Yuan J, Narayanan L, Rockwell S, Glazer PM. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 2000; 60:4372-6.
29. Mihaylova VT, Bindra RS, Yuan J, Campisi D, Narayanan L, Jensen R, et al. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol 2003; 23:3265-73.
30. Koshiji M, To KK, Hammer S, Kumamoto K, Harris AL, Modrich P, et al. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell 2005; 17:793-803.
31. Bindra RS, Glazer PM. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. Cancer Lett 2007; 252:93-103.
32. Bindra RS, Schaffer PJ, Meng A, Woo J, Maseide K, Roth ME, et al. Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability. Ann NY Acad Sci 2005; 1059:184-95.
33. de Laat WL, Jaspers NG, Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev 1999; 13:768-85.
34. Ma L, Hoeijmakers JH, van der Eb AJ. Mammalian nucleotide excision repair. Biochim Biophys Acta 1995; 1242:137-63.
35. Sancar A. DNA excision repair. Annu Rev Biochem 1996; 65:43-81.
36. Wood RD. DNA repair in eukaryotes. Annu Rev Biochem 1996; 65:135-67.
37. Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998; 2:223-32.
38. van Hoffen A, Balajee AS, van Zeeland AA, Mullenders LH. Nucleotide excision repair and its interplay with transcription. Toxicology 2003; 193:79-90.
39. Dominguez-Brauer C, Chen YJ, Brauer PM, Pimkina J, Raychaudhuri P. ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4. EMBO Rep 2009; 10:1036-42.
40. Sharpless E, Chin L. The INK4a/ARF locus and melanoma. Oncogene 2003; 22:3092-8.
41. ARF. J Biol Chem 2001; 276:41424-34.
42. ARF. Oncogene 2001; 20:5543-7.
43. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-54.
44. Herlyn M, Satyamoorthy K. Activated ras. Yet another player in melanoma? Am J Pathol 1996; 149:739-44.
45. O'Hagan RC, Brennan CW, Strahs A, Zhang X, Kannan K, Donovan M, et al. Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma. Cancer Res 2003; 63:5352-6.
46. Yang G, Curley D, Bosenberg MW, Tsao H. Loss of Xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. Cancer Res 2007; 67:5649-57.
47. Bindra RS, Schaffer PJ, Meng A, Woo J, Maseide K, Roth ME, et al. Downregulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol 2004; 24:8504-18.
48. Lowe SW, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003; 13:77-83.